PharmaReports: Psychiatric, Addictive & Sleep Disorders
LeadDiscovery offers full reports in selected areas of the pharmaceutical and biotech sector.
Each of the reports below has been especially selected by LeadDiscovery. Browse the reports or try our search engine.
This channel focuses on the main psychiatric diseases such as depression, bipolar disease, anxiety and schizophrenia although reports focusing on neuroelectrophysiology (for example epilepsy) are also included here. Likewise reports relating to addictive, sleep and attention deficit disorders are also included here.
Showing results 1 - 50 of 112
- Psychotherapeutics: Antidepressants, Antipsychotics, Antianxiety Drugs, World Market
- The Impact of the Phase III Pipeline: Future Projections and Market Disruptions
- Smoking Cessation and Addiction Treatments: A World Market Analysis
- Proteomics - Technologies, Markets and Companies
- Transdermal Drug Delivery - Technologies, Markets, and Companies
- Alzheimer disease - new drugs, markets and companies
- Gene Therapy - technologies, markets and companies
- Drug Delivery in Central Nervous System Diseases - technologies,markets and companies
- Biomarkers - technologies,markets and companies
- The World Schizophrenia Market 2005-2010
- Anti-addiction Therapies, 2006-2011
- Early Toxicology: Markets and Approaches
- Biotech Drug Delivery Systems - Key Company Intelligence & Market Outlook to 2012
- Monoclonal Antibodies 2007
- The Global Protein Therapeutics Market
- Biogenerics
- Cell-Based Assays for Drug Discovery
- Personalized Medicine
- ANXIETY - Therapy Area Pipeline Report
- DEMENTIA - Therapy Area Pipeline Report
- DEPRESSION - Therapy Area Pipeline Report
- INSOMNIA and SLEEP DISORDERS - Therapy Area Pipeline Report
- SCHIZOPHRENIA - Therapy Area Pipeline Report
- IRRITABLE BOWEL SYNDROME (IBS) - Therapy Area Pipeline Report
- SMOKING CESSATION - Therapy Area Pipeline Report
- Global Smoking Cessation Market Analysis & Forecasts - Preparing for the First Blockbuster
- Top Companies and Products in the RNA/DNA Therapy Products Market
- Anti-Obesity Treatments 2007-2012 - A blockbuster market
- Pipeline Report - Neuronal alpha 7 nicotinic receptors: Candidates for the treatment of Alzheimers disease and Schizophrenia
- Pediatric Drugs - the Worldwide Market
- Gene Expression Profiling Markets
- UpdatesPlus-Nicotinic Receptors (January 2008)
- How to Conduct Clinical Trials in China
- UpdatesPlus-Nicotinic Receptors (February 2008)
- Stem Cells: Worldwide Markets for Transplantation, Cord Blood Banking and Drug Development
- Neuronal Nicotinic Receptors: UpdatesPlus March 2008
- Biogenerics - The World Market: Biosimilars and Biologics at a Crossroads
- Neuronal Nicotinic Receptors - April 2008
- Outsourcing in Drug Discovery
- Sleep Disorders Market Analysis 2008-2018
- Antipsychotics Market Insight and Analysis 2008
- Neuronal Nicotinic Receptors - June 2008
- Neuronal Nicotinic Receptors - July 2008
- Neuronal Nicotinic Receptors - August 2008
- Neuronal Nicotinic Receptors - September 2008
- Ion Channel Trends 2008
- GPCR Screening & Profiling Trends 2008
- Neuronal Nicotinic Receptors - October 2008
- The Global Anti-Addiction Market, 2008-2023
- Neuronal Nicotinic Receptors - November 2008
Browse our theraputic areas for other entries:
- Oncology
- Cancer Immunotherapy
- Immunology & Inflammatory Diseases
- Infectious Diseases
- Psychiatric, Addictive & Sleep Disorders
- Pain
- Neurodegenerative & Neuroelectrophysiological Disorders
- Metabolic & Hormonal Disorders
- Cardiovascular Disorders
- GenitoUrinary Tract Disorders
- Technology
- Diagnostics & Devices
- Other Theraputic Areas, Pharmaceutical Strategy and Development